Molecular Epidemiology of Programmed Cell Death 1-Ligand 1 (PD-L1) Protein Expression in Non-Small Cell Lung Cancer

被引：0
|
作者：
Schabath, Matthew [1 ]
Dalvi, Tapashi [2 ]
Dai, Hongyue [3 ]
Crim, Alan [3 ]
Midha, Anita [4 ]
Shire, Norah [2 ]
Walker, Jill
Greenawalt, Danielle [5 ]
Lawrence, David
Rigas, James [6 ]
Brody, Robert [2 ]
Potter, Danielle [2 ]
Kumar, Naveen [3 ]
Huntsman, Shane [3 ]
Grays, Jhanelle [7 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol, Tampa, FL USA
[2] Astrazeneca, Gaithersburg, MD USA
[3] M2Gen, Tampa, FL USA
[4] Astrazeneca, Chester, Cheshire, England
[5] Astrazeneca, Waltham, MA USA
[6] Astrazeneca, Hanover, NH USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
PD-L1; lung cancer; epidemiology; Immunotherapy;
D O I：
10.1016/j.jtho.2016.11.566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-042
引用
收藏
页码：S475 / S476
页数：2
相关论文
共 50 条
  • [1] Expression analysis of programmed cell death 1 ligand 1 (PD-L1) in patients with non-small cell lung cancer
    Peng, Nanqiu
    Qin, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 15 (01): : 1 - 5
  • [2] A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer
    Schabath, Matthew B.
    Dalvi, Tapashi B.
    Dai, Hongyue A.
    Crim, Alan L.
    Midha, Anita
    Shire, Norah
    Gimbrone, Nicholas T.
    Walker, Jill
    Greenawalt, Danielle M.
    Lawrence, David
    Rigas, James R.
    Brody, Robert
    Potter, Danielle
    Kumar, Naveen S.
    Huntsman, Shane A.
    Gray, Jhanelle E.
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9469 - 9481
  • [3] Programmed Death Ligand 1 (PD-L1) Expression in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
    D'Arcangelo, M.
    Puccetti, M.
    Bravaccini, S.
    D'Incecco, A.
    Ligorio, C.
    Terracciano, L.
    Damiani, S.
    Ravaioli, S.
    Tumedei, M. M.
    Bennati, C.
    Minuti, G.
    Vecchiarelli, S.
    Landi, L.
    Incarbone, M.
    Milesi, M.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2390 - S2390
  • [4] Circulating Programmed Death Ligand-1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
    Vecchiarelli, S.
    D'Incecco, A.
    Minuti, G.
    Gallo, M.
    De Luca, A.
    Landi, L.
    Bennati, C.
    Spreafico, M.
    D'Arcangelo, M.
    Attilia, L.
    Mazza, V.
    Normanno, N.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2389 - S2389
  • [5] Circulating programmed death ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC)
    Vecchiarelli, S.
    D'Incecco, A.
    Gallo, M.
    De Luca, A.
    Minuti, G.
    Landi, L.
    Bennati, C.
    Spreafico, M.
    D'Arcangelo, M.
    Attilia, L.
    Mazza, V.
    Normanno, N.
    Cappuzzo, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] Programmed death ligand-1 (PD-L1) heterogeneity in non-small cell lung cancer (NSCLC)
    McLaughlin, Joseph
    Schalper, Kurt A.
    Carvajal-Hausdorf, Daniel E.
    Pelekanou, Vasiliki
    Velcheti, Vamsidhar
    Haack, Herbert
    Silver, Matthew R.
    Herbst, Roy
    LoRusso, Patricia
    Rimm, David L.
    CANCER RESEARCH, 2015, 75
  • [7] Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancer
    Pan, Yunjian
    Zheng, Difan
    Li, Yuan
    Cai, Xu
    Zheng, Zongli
    Jin, Yan
    Hu, Haichuan
    Cheng, Chao
    Shen, Lei
    Wang, Jian
    Ji, Hongbin
    Sun, Yihua
    Zhou, Xiaoyan
    Chen, Haiquan
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2579 - 2586
  • [8] Spatiotemporal Effects on Programmed Death Ligand 1 (PD-L1) Expression and Immunophenotype of Non-Small Cell Lung Cancer (NSCLC)
    Kowanetz, Marcin
    Koeppen, Hartmut
    Boe, Marigold
    Chaft, Jamie E.
    Rudin, Charles M.
    Zou, Wei
    Nickles, Dorothee
    Desai, Rupal
    Nakamura, Rin
    Sandler, Alan
    Amler, Lukas
    Hegde, Priti
    Rizvi, Naiyer A.
    Hellmann, Matthew D.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S199 - S199
  • [9] Clinicopathological features of programmed cell death ligand 1 (PD-L1) expression in resected non-small cell lung cancers
    Ohhara, Yoshihito
    Kinoshita, Ichiro
    Tomaru, Utano
    Hatanaka, Kanako C.
    Hatanaka, Yutaka
    Honma, Rio
    Takeuchi, Satoshi
    Shimizu, Yasushi
    Kaga, Kichizo
    Matsuno, Yoshihiro
    Dosaka-Akita, Hirotoshi
    CANCER RESEARCH, 2017, 77
  • [10] Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer
    Sepesi, Boris
    Cuentas, Edwin Parra
    Canales, Jaime Rodriguez
    Behrens, Carmen
    Correa, Arlene M.
    Vaporciyan, Ara
    Weissferdt, Annikka
    Kalhor, Neda
    Moran, Cesar
    Swisher, Stephen
    Wistuba, Ignacio
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2017, 29 (03) : 408 - 415
12345